Irofulven hydroxymethylacylfulvene (MGI 114): Began Phase I trial

MGI Pharma Inc. (MOGN), Bloomington, Minn.
Product: Irofulven hydroxymethylacylfulvene

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE